tiprankstipranks
Trending News
More News >
Iofina PLC (GB:IOF)
LSE:IOF
Advertisement

Iofina plc (IOF) AI Stock Analysis

Compare
15 Followers

Top Page

GB:IOF

Iofina plc

(LSE:IOF)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
26.00p
▲(10.64% Upside)
Iofina plc's overall stock score is driven by its stable financial position and reasonable valuation. However, challenges in profitability and lack of strong market momentum temper the overall outlook.

Iofina plc (IOF) vs. iShares MSCI United Kingdom ETF (EWC)

Iofina plc Business Overview & Revenue Model

Company DescriptionIofina plc engages in the exploration and production of iodine, iodine specialty chemical derivatives, produced water, and natural gas in the United States and the United Kingdom. It offers halogen chemicals, disinfectants, electronic specialty gases, sanitizers, heat stabilizers, preservatives, and specialty intermediates, as well as animal health, mineral separation, and odor control products for use in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, and nylon markets. The company also provides turnkey mid-stream fee based solutions to third party brine stream operators to extract iodine. Iofina plc was founded in 2005 and is based in London, the United Kingdom.
How the Company Makes MoneyIofina generates revenue primarily through the sale of high-purity iodine and iodine derivatives, which are sold to various sectors including pharmaceuticals, agricultural chemicals, and industrial applications. The company employs a unique extraction technology that allows it to efficiently recover iodine from brine, enabling a competitive cost structure. Key revenue streams include direct sales to manufacturers and distributors in these sectors. Additionally, Iofina may engage in strategic partnerships or contracts with companies that require consistent iodine supply, further solidifying its market position and ensuring stable cash flows. Fluctuations in iodine pricing and demand dynamics in end-use markets also significantly influence the company’s earnings.

Iofina plc Financial Statement Overview

Summary
Iofina plc demonstrates a stable financial position with low leverage and strong cash flow generation. However, declining profitability margins and return on equity indicate challenges in maintaining growth and efficiency.
Income Statement
65
Positive
Iofina plc has shown a moderate revenue growth rate of 5.32% in the latest year, with a declining trend in gross profit margin from 31.29% to 24.30%. The net profit margin also decreased from 13.12% to 5.36%, indicating pressure on profitability. The EBIT and EBITDA margins have similarly declined, reflecting challenges in maintaining operational efficiency.
Balance Sheet
75
Positive
The company has a strong balance sheet with a low debt-to-equity ratio of 0.09, indicating low leverage and financial stability. However, the return on equity has decreased from 14.67% to 6.11%, suggesting reduced profitability on shareholder investments. The equity ratio remains robust, highlighting a solid capital structure.
Cash Flow
70
Positive
Iofina plc's free cash flow growth rate has significantly improved by 72.67%, showing enhanced cash generation capabilities. The operating cash flow to net income ratio is healthy at 0.93, indicating efficient cash conversion. However, the free cash flow to net income ratio has decreased, reflecting potential challenges in translating earnings into free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue57.65M54.47M50.04M42.20M39.04M29.69M
Gross Profit14.36M13.24M15.65M15.83M10.73M8.40M
EBITDA8.37M7.65M10.64M11.36M6.85M4.61M
Net Income4.82M2.92M6.56M7.87M9.19M1.28M
Balance Sheet
Total Assets70.23M63.78M60.52M52.71M44.45M39.83M
Cash, Cash Equivalents and Short-Term Investments6.42M6.86M6.52M5.93M5.26M4.38M
Total Debt7.47M4.26M5.84M7.20M8.68M12.62M
Total Liabilities19.91M15.99M15.77M14.73M14.48M19.18M
Stockholders Equity50.32M47.79M44.75M37.97M29.96M20.66M
Cash Flow
Free Cash Flow-1.70M2.02M2.34M2.46M6.41M1.33M
Operating Cash Flow8.37M11.53M8.57M5.55M7.89M3.78M
Investing Cash Flow-9.94M-9.34M-6.10M-3.07M-1.47M-2.43M
Financing Cash Flow2.19M-1.85M-1.88M-1.81M-4.64M-6.58M

Iofina plc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price23.50
Price Trends
50DMA
24.09
Negative
100DMA
24.58
Negative
200DMA
23.22
Positive
Market Momentum
MACD
-0.04
Negative
RSI
48.37
Neutral
STOCH
35.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IOF, the sentiment is Negative. The current price of 23.5 is above the 20-day moving average (MA) of 23.36, below the 50-day MA of 24.09, and above the 200-day MA of 23.22, indicating a neutral trend. The MACD of -0.04 indicates Negative momentum. The RSI at 48.37 is Neutral, neither overbought nor oversold. The STOCH value of 35.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:IOF.

Iofina plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
£45.09M12.1110.25%8.48%29.33%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
£214.18M304.860.60%1.73%15.56%-92.94%
55
Neutral
£25.07M-1.57-27.64%35.09%
53
Neutral
£6.31M-11.10%14.51%77.27%
50
Neutral
£14.16M-14.69-12.88%25.56%35.12%
45
Neutral
£8.09M-2.23-78.76%-24.85%40.28%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:IOF
Iofina plc
23.50
5.50
30.56%
GB:DCTA
Directa Plus
7.75
-3.50
-31.11%
GB:HDD
Hardide
8.00
3.25
68.42%
GB:HAYD
Haydale Graphene
0.58
0.43
286.67%
GB:ITX
Itaconix
105.00
-12.50
-10.64%
GB:ZTF
Zotefoams
439.00
90.57
25.99%

Iofina plc Corporate Events

Business Operations and StrategyFinancial Disclosures
Iofina Achieves Record Iodine Production in Q3 2025
Positive
Oct 16, 2025

Iofina plc reported a record quarter in iodine production, achieving a 32% year-on-year increase with 215.8 metric tonnes produced in Q3 2025. The company attributes this growth to the successful operation of its eight IOsorb® plants in Oklahoma, including the new IO#11 plant. With strong iodine prices and demand, Iofina is optimistic about meeting its production targets for the second half of the year and is in the final stages of negotiations for its IO#12 plant, indicating continued expansion and positive outlook into 2026.

The most recent analyst rating on (GB:IOF) stock is a Hold with a £25.00 price target. To see the full list of analyst forecasts on Iofina plc stock, see the GB:IOF Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Iofina Achieves Record Revenue and Iodine Production in H1 2025
Positive
Sep 18, 2025

Iofina plc reported record revenues and iodine production for the first half of 2025, with a 12.3% increase in revenue to $29.2 million and a 21.2% rise in gross profit to $6.3 million. The company achieved a 10.6% increase in iodine production, supported by strong market demand and high iodine prices. The commissioning of the new IO#11 plant is expected to significantly contribute to future production, with the company anticipating production of 400-440 metric tonnes of crystalline iodine in the second half of 2025. Iofina remains well-positioned to continue its growth strategy, leveraging strong cash generation and banking facilities to finance ongoing operational investments.

Business Operations and StrategyFinancial Disclosures
Iofina Achieves Record Iodine Production and Boosts Cash Reserves
Positive
Sep 4, 2025

Iofina plc announced a record monthly iodine production of 74.3 metric tons in August 2025, attributed to efficient operations and the addition of a new plant, IO#11, to its portfolio. The company also reported a $1.8 million increase in cash reserves, thanks to Employee Retention Tax Credit refunds received for retaining employees during the COVID-19 pandemic. These developments underscore Iofina’s commitment to growth and operational efficiency, as it plans to expand into new areas and enhance future iodine production.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025